06:00 UTC Charta Aetatis Cyberpunk

Console Newsletter Pro Sign in Early access Register
Aa · Display
Themes
Type size
Density
MorningStar Security is in early access. The wiki is open to everyone; the news desks open with a code. Have a code, or want launch notice?
Export
growing · 5 feeds

GLP-1 receptor agonists

News volume 1 story in 90 days
23 Aug: 0 stories24 Aug: 0 stories25 Aug: 0 stories26 Aug: 0 stories27 Aug: 0 stories28 Aug: 0 stories29 Aug: 0 stories30 Aug: 0 stories31 Aug: 0 stories1 Sep: 0 stories2 Sep: 0 stories3 Sep: 1 story4 Sep: 0 stories5 Sep: 0 stories6 Sep: 0 stories7 Sep: 0 stories8 Sep: 0 stories9 Sep: 0 stories10 Sep: 0 stories11 Sep: 0 stories12 Sep: 0 stories13 Sep: 0 stories14 Sep: 0 stories15 Sep: 0 stories16 Sep: 0 stories17 Sep: 0 stories18 Sep: 0 stories19 Sep: 0 stories20 Sep: 0 stories21 Sep: 0 stories22 Sep: 0 stories23 Sep: 0 stories24 Sep: 0 stories25 Sep: 0 stories26 Sep: 0 stories27 Sep: 0 stories28 Sep: 0 stories29 Sep: 0 stories30 Sep: 0 stories1 Oct: 0 stories2 Oct: 0 stories3 Oct: 0 stories4 Oct: 0 stories5 Oct: 0 stories6 Oct: 0 stories7 Oct: 0 stories8 Oct: 0 stories9 Oct: 0 stories10 Oct: 0 stories11 Oct: 0 stories12 Oct: 0 stories13 Oct: 0 stories14 Oct: 0 stories15 Oct: 0 stories16 Oct: 0 stories17 Oct: 0 stories18 Oct: 0 stories19 Oct: 0 stories20 Oct: 0 stories21 Oct: 0 stories22 Oct: 0 stories23 Oct: 0 stories24 Oct: 0 stories25 Oct: 0 stories26 Oct: 0 stories27 Oct: 0 stories28 Oct: 0 stories29 Oct: 0 stories30 Oct: 0 stories31 Oct: 0 stories1 Nov: 0 stories2 Nov: 0 stories3 Nov: 0 stories4 Nov: 0 stories5 Nov: 0 stories6 Nov: 0 stories7 Nov: 0 stories8 Nov: 0 stories9 Nov: 0 stories10 Nov: 0 stories11 Nov: 0 stories12 Nov: 0 stories13 Nov: 0 stories14 Nov: 0 stories15 Nov: 0 stories16 Nov: 0 stories17 Nov: 0 stories18 Nov: 0 stories19 Nov: 0 stories20 Nov: 0 stories
Snapshot
Field
biotech 1 source
Nature
compound 1 source
Maturity
commercial 1 source
Intelligence coverage

GLP-1 receptor agonists are compounds that activate glucagon-like peptide-1 receptors, developed within the biotech field and currently at commercial maturity 1.

Clinical Applications

These agents are established treatments for type 2 diabetes and weight loss 2. Emerging research suggests they may reduce the risk of serious infections, including tuberculosis, in type 2 diabetes patients, though this evidence remains preliminary 3. Potential applications in weight management and anti-aging have been proposed, but these remain speculative 4.

Facts 3

AttributeValueConfidenceSourcesCited
Field biotech low 1 1
Nature compound low 1 1
Maturity commercial low 1 1

Applications 3

  • May reduce risk of serious infections including tuberculosis in type 2 diabetes patients
  • diabetes treatment, weight management, potential anti-aging
  • diabetes treatment and weight loss

Frequently mentioned together 8

Sources 8

  1. Yo-yo dieting takes on a new shape in the age of Ozempic · New Atlas
  2. video How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski · Huberman Lab
  3. GLP-1s are being linked to fewer serious infections, including TB · Hacker News (YC)
  4. Are GLP-1 Drugs a ‘Fountain of Youth’? Doctors Explain Health Benefits Beyond Weight Loss - TODAY.com · Google News: Hacking
  5. How Demand for GLP-1s Overwhelmed the Global Drug System · Council on Foreign Relations
That's Frontier for today

Tomorrow's desk, in your inbox by 06:00 UTC. The week's best stories, every Sunday. The month that mattered, on the 1st.

Drawn from the 519 sources the paper read this month. Text and HTML, one-click unsubscribe, free.

How often
Your desks